Recursion Pharmaceuticals Inc Cl A (RXRX) Stock Price, Quote & News

Company Profile

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-12...

Industry: Biotechnology

Sector: Healthcare

Phone: 385 269 0203

Website: www.recursion.com

Address:

41 South Rio Grande Street, Salt Lake City, United States

stockcage Apr. 4 at 9:59 PM

$RXRX https://www.instagram.com/reel/DWtdZSiCYuI/

0 · Reply

Spartangio Apr. 4 at 9:47 PM

$RXRX

0 · Reply

AStrokeOfLuck Apr. 4 at 7:10 PM

$MRNA $RLAY $RXRX $ABSI $SPY

0 · Reply

JennyRowes Apr. 4 at 3:36 PM

$ABSI $ABCL $RXRX $GENB absi -15% ytd, 30% short abcl +3% ytd, 22% short rxrx -26% ytd, 35% short genb +9% ytd ??? short

0 · Reply

Invest2live Apr. 4 at 2:24 PM

$NOK 105% already; congrats 🌿🎈🌿 Checkout $RXRX and $BDTX

0 · Reply

Invest2live Apr. 4 at 1:22 AM

$ELUT 59% already; congrats 🌿🎈🌿 Checkout $GAU and $RXRX

0 · Reply

Toptradersam Apr. 3 at 7:42 PM

$GNPX $NRXS $ZBCN.X $RXRX Don’t ignore this $1.5 penny stock ⚠️ Momentum could hit FAST 💸 See why in my latest video 👇 https://www.youtube.com/watch?v=mKJv0sQCxdY

0 · Reply

WallStreetBuyDip Apr. 3 at 4:17 PM

Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.

0 · Reply

IAmSpoli Apr. 3 at 3:37 PM

$RXRX this is looking like an attractive r/w

0 · Reply

theRockSeys Apr. 3 at 2:28 PM

$RXRX https://www.statnews.com/2026/04/02/biotech-takeovers-cytokinetics-biogen/ ceo must be confident if we are not doing M&A then you better have working product or this company will be done. Hiring someone that use to work with fda. This is going to get drug approved, buckle up ai Drug discovery is going to change everything

0 · Reply

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform

Mar 25, 2026, 7:59 AM EDT - 11 days ago

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Mar 20, 2026, 8:02 PM EDT - 15 days ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Mar 6, 2026, 12:35 PM EST - 4 weeks ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Feb 25, 2026, 12:47 PM EST - 5 weeks ago

Recursion Pharmaceuticals, Inc. (RXRX) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 6:30 AM EST - 5 weeks ago

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 23, 2026, 8:00 AM EST - 5 weeks ago

Recursion To Be Featured in HighRes' Lightning Talk at NVIDIA GTC

Feb 23, 2026, 7:55 AM EST - 5 weeks ago

Recursion to Participate in Upcoming Investor Conferences

Feb 18, 2026, 8:30 AM EST - 6 weeks ago

Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25

Feb 18, 2026, 5:43 AM EST - 6 weeks ago

Applied Digital, Recursion Pharmaceuticals Stocks Drop. Blame Nvidia.

APLD NVDA

Jan 22, 2026, 2:54 PM EST - 2 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference Transcript

Jan 13, 2026, 5:46 PM EST - 2 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 6, 2026, 7:59 AM EST - 3 months ago

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

Dec 26, 2025, 1:28 PM EST - 3 months ago

3 Small AI Plays to Buy for 2026

ANET INOD

Dec 18, 2025, 11:38 AM EST - 3 months ago

Recursion Pharmaceuticals: Upgrading To Buy - My Most Surprising Call Of 2025

Dec 18, 2025, 11:05 AM EST - 3 months ago

What's Happening With RXRX Stock?

Dec 8, 2025, 4:37 PM EST - 4 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Discusses Updated Safety and Efficacy Data from TUPELO Phase I/II Study of REC-4881 in FAP Transcript

Dec 8, 2025, 7:32 AM EST - 4 months ago

Recursion Pharma's AI-powered therapy reduces colon growth in a rare disease trial

Dec 8, 2025, 7:30 AM EST - 4 months ago

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

Dec 5, 2025, 8:19 AM EST - 4 months ago

Jim Cramer: This Health Care Stock Has Been 'Horrendous'

Dec 1, 2025, 8:30 AM EST - 4 months ago

Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025

Nov 21, 2025, 7:43 PM EST - 4 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 10:14 AM EST - 4 months ago

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Nov 5, 2025, 8:11 PM EST - 5 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 6:30 AM EST - 5 months ago

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 5, 2025, 6:28 AM EST - 5 months ago

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

Oct 28, 2025, 8:00 AM EDT - 5 months ago

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

Oct 22, 2025, 1:42 PM EDT - 5 months ago

Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks

AI APLD ENVX HIMS IBRX PLUG RKT

Oct 8, 2025, 2:51 PM EDT - 6 months ago

What's Going On With Recursion Pharmaceuticals Stock On Wednesday?

Sep 8, 2025, 8:03 PM EDT - 7 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 3, 2025, 6:51 PM EDT - 7 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 5, 2025, 2:44 PM EDT - 8 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 6:30 AM EDT - 8 months ago

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 29, 2025, 8:00 AM EDT - 8 months ago

Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th

Jul 25, 2025, 1:53 PM EDT - 9 months ago

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma

NVDA PLTR

Jul 22, 2025, 7:02 AM EDT - 9 months ago

Top 2 Health Care Stocks You May Want To Dump This Quarter

MEDP

Jun 10, 2025, 6:14 AM EDT - 10 months ago

Recursion to lay off 20% of workforce, narrows focus amid biotech downturn

Jun 6, 2025, 10:00 AM EDT - 10 months ago

MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy

May 5, 2025, 1:37 PM EDT - 11 months ago

Recursion Pharmaceuticals, Inc. (RXRX) Q1 2025 Earnings Call Transcript

May 5, 2025, 6:00 AM EDT - 11 months ago

Recursion Reports First Quarter 2025 Financial Results and Provides Business Update

May 5, 2025, 4:02 AM EDT - 11 months ago

Recursion Pharmaceuticals: Looking For Entry Around Q1 Earnings

May 4, 2025, 12:45 PM EDT - 11 months ago

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

Apr 28, 2025, 8:27 AM EDT - 1 year ago

Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th

Apr 22, 2025, 8:34 PM EDT - 1 year ago

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025

Apr 16, 2025, 8:30 AM EDT - 1 year ago

HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data

Apr 9, 2025, 8:00 AM EDT - 1 year ago

Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Recursion to Participate in Upcoming Investor Conference

Mar 3, 2025, 11:19 AM EST - 1 year ago

Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says

Feb 28, 2025, 1:16 PM EST - 1 year ago

Recursion Pharmaceuticals, Inc. (RXRX) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 6:30 AM EST - 1 year ago

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

stockcage Apr. 4 at 9:59 PM

$RXRX https://www.instagram.com/reel/DWtdZSiCYuI/

0 · Reply

Spartangio Apr. 4 at 9:47 PM

$RXRX

0 · Reply

AStrokeOfLuck Apr. 4 at 7:10 PM

$MRNA $RLAY $RXRX $ABSI $SPY

0 · Reply

JennyRowes Apr. 4 at 3:36 PM

$ABSI $ABCL $RXRX $GENB absi -15% ytd, 30% short abcl +3% ytd, 22% short rxrx -26% ytd, 35% short genb +9% ytd ??? short

0 · Reply

Invest2live Apr. 4 at 2:24 PM

$NOK 105% already; congrats 🌿🎈🌿 Checkout $RXRX and $BDTX

0 · Reply

Invest2live Apr. 4 at 1:22 AM

$ELUT 59% already; congrats 🌿🎈🌿 Checkout $GAU and $RXRX

0 · Reply

Toptradersam Apr. 3 at 7:42 PM

$GNPX $NRXS $ZBCN.X $RXRX Don’t ignore this $1.5 penny stock ⚠️ Momentum could hit FAST 💸 See why in my latest video 👇 https://www.youtube.com/watch?v=mKJv0sQCxdY

0 · Reply

WallStreetBuyDip Apr. 3 at 4:17 PM

0 · Reply

IAmSpoli Apr. 3 at 3:37 PM

$RXRX this is looking like an attractive r/w

0 · Reply

theRockSeys Apr. 3 at 2:28 PM

0 · Reply

Brodman Apr. 2 at 8:48 PM

$RXRX 1st decent week in months....if they get a drug approved, the first in 12 years it might get back to $6, that a big if!!!!

1 · Reply

Brittymane Apr. 2 at 7:00 PM

$RXRX slow at first, then all at once!! This company has a great future

0 · Reply

theRockSeys Apr. 2 at 6:37 PM

$RXRX after hours they try to kick it down and then you get these random blips up.

0 · Reply

Lh2838 Apr. 2 at 4:31 PM

$RXRX AI is used by drug developers and we want that," FDA commissioner Marty Makary said at a PhRMA event last month. "We want to see more of that." The FDA is basically saying: “We’re open for business if AI makes drugs better, faster, or safer.” 👌

0 · Reply

LoveRetailFroth Apr. 2 at 2:36 PM

$RXRX 🚀🚀🚀

0 · Reply

LoveRetailFroth Apr. 2 at 2:35 PM

$RXRX Quickly $10 plus with 200 million short🤣🚀

0 · Reply

Spartangio Apr. 2 at 1:56 PM

$RXRX

1 · Reply

LoveRetailFroth Apr. 2 at 1:56 PM

$RXRX Good Morning ☕️ 💪 despite a lunatic in the WH! $AMLX $SANA $TMT.X

1 · Reply

theRockSeys Apr. 2 at 12:35 PM

$RXRX the games played on this stock very manipulated

0 · Reply

Zio_Fauss Apr. 2 at 11:50 AM

$RXRX probably…!

0 · Reply

Spartangio Apr. 2 at 3:37 AM

$RXRX Trumps speech not the best Crude oil over 104 bearish post on rxrx coming soon

1 · Reply

Market Cap	1.64B
Revenue (ttm)	74.68M
Net Income (ttm)	-644.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-863.36%
Debt to Equity Ratio	0.01

Volume	9,290,500
Avg Vol	18,018,627
Day's Range	N/A - N/A
Shares Out	527.40M
Stochastic %K	58%
Beta	1.02
Analysts	Sell
Price Target	$6.71